Related references
Note: Only part of the references are listed.Systematic review of associations between concomitant rheumatoid arthritis and peripheral arterial disease, health-related quality of life and functional capacity
Tayser Zoubi et al.
RHEUMATOLOGY INTERNATIONAL (2023)
Effect of anti-inflammatory therapy on vascular biomarkers for subclinical cardiovascular disease in rheumatoid arthritis patients
Annelies B. Blanken et al.
RHEUMATOLOGY INTERNATIONAL (2023)
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Steven Hageman et al.
EUROPEAN HEART JOURNAL (2021)
Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
James P. Howard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
Bryant R. England et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
Bryant R. England et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
R. Agca et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries
Cynthia S. Crowson et al.
RHEUMATOLOGY (2017)
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
Elke E. A. Arts et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
M. J. L. Peters et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)